Kathmere Capital Management »

Biogen Idec shares owned by Kathmere Capital Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Kathmere Capital Management from 13F filings

Historical chart of Kathmere Capital Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Kathmere Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Kathmere Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $843k 4.8k 175.99
2025-09-30 $346k 2.5k 140.08
2025-06-30 $209k 1.7k 125.59
2024-06-30 $212k 820 258.77
2023-12-31 $212k 820 258.77
2023-09-30 $233k 907 257.01
2023-06-30 $258k 907 284.85
2020-12-31 $89k 362 245.86
2020-09-30 $103k 362 284.53
2019-12-31 $273k 921 296.42